ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 78 filers reported holding ENZO BIOCHEM INC in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $352,000 | -17.6% | 102,282 | -39.6% | 0.00% | -33.3% |
Q4 2020 | $427,000 | +55.3% | 169,430 | +29.9% | 0.00% | -25.0% |
Q3 2020 | $275,000 | +848.3% | 130,462 | +896.7% | 0.00% | – |
Q2 2020 | $29,000 | -85.0% | 13,089 | -82.2% | 0.00% | -100.0% |
Q4 2019 | $193,000 | -14.2% | 73,442 | +17.7% | 0.00% | -50.0% |
Q3 2019 | $225,000 | -39.2% | 62,387 | -43.2% | 0.00% | -50.0% |
Q2 2019 | $370,000 | -38.3% | 109,776 | -50.1% | 0.00% | -33.3% |
Q1 2019 | $600,000 | +6.2% | 219,952 | +8.1% | 0.01% | -14.3% |
Q4 2018 | $565,000 | -4.9% | 203,402 | +41.2% | 0.01% | 0.0% |
Q3 2018 | $594,000 | +53.9% | 144,056 | +93.6% | 0.01% | +40.0% |
Q2 2018 | $386,000 | +75.5% | 74,400 | +85.1% | 0.01% | +66.7% |
Q1 2018 | $220,000 | -29.9% | 40,198 | +4.3% | 0.00% | -40.0% |
Q4 2017 | $314,000 | -34.9% | 38,524 | -16.3% | 0.01% | -44.4% |
Q3 2017 | $482,000 | +282.5% | 46,000 | +303.5% | 0.01% | +350.0% |
Q2 2017 | $126,000 | +61.5% | 11,400 | +1.4% | 0.00% | -33.3% |
Q4 2016 | $78,000 | – | 11,238 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
Ergoteles LLC | 177,048 | $627,000 | 0.02% |
FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |